|
GB201521903D0
|
|
Isorbaric mass labels
|
|
GB201521919D0
|
|
Isobaric mass labels
|
|
GB201519186D0
|
|
Isotopic methods for measurement of tryptophan and metabolites thereof
|
|
GB201509134D0
|
|
Biomolecules involved in Alzheimer's disease
|
|
GB201508276D0
|
|
A casein kinase 1 delta inhibitor
|
|
GB201504432D0
|
|
Materials and methods for diagnosis and treatment of alzheimers disease
|
|
GB201410523D0
|
|
Mass labels
|
|
GB201322567D0
|
|
Mass labels
|
|
GB201322094D0
|
|
Methods and compositions relating to alzheimers disease
|
|
GB201320061D0
|
|
Materials nad methods for diagnosis and prognosis of liver cancer
|
|
GB201314485D0
|
|
Materials and methods relating to pancreatic cancer
|
|
GB201310203D0
|
|
Materials and methods relating to Alzheimer's disease
|
|
GB201310150D0
|
|
Methods and compositions relating to alzheimer's disease
|
|
GB201308765D0
|
|
Mass Tag Reagents
|
|
CA2844546A1
|
|
Materials and methods for determining sensitivity potential of compounds
|
|
AU2012270053A1
|
|
Materials and methods for determining sensitivity potential of compounds
|
|
GB201205173D0
|
|
Methods and compositions relating to neurocognitive disorders
|
|
EP2651405A2
|
|
Casein kinase 1 (ck1 ) inhibitors
|
|
GB201109162D0
|
|
Casein kinase 1Delta (CK1Delta) inhibitors
|
|
GB201021161D0
|
|
Casein kinase 1delta (CK1Delta) inhibitors
|
